APA (7th ed.) Citation

Guolo, F., Minetto, P., Pesce, S., Ballerini, F., Greppi, M., Bozzo, M., . . . Lemoli, R. M. (2023). Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells. Blood, 142(Supplement 1), 2218. https://doi.org/10.1182/blood-2023-189574

Chicago Style (17th ed.) Citation

Guolo, Fabio, et al. "Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells." Blood 142, no. Supplement 1 (2023): 2218. https://doi.org/10.1182/blood-2023-189574.

MLA (8th ed.) Citation

Guolo, Fabio, et al. "Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells." Blood, vol. 142, no. Supplement 1, 2023, p. 2218, https://doi.org/10.1182/blood-2023-189574.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.